Processa Pharmaceuticals Inc. reconvened its Annual Shareholder Meeting on July 30, 2025. The proposals presented during the meeting included the election of board members and the ratification of the appointment of the independent registered public accounting firm. The election of board members was approved, as was the ratification of the appointment of the accounting firm.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.